ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

Recursion Pharmaceuticals, Inc. (RXRX)

Nasdaq · Common stock · Biological Products, (no Diagnostic Substances)

$3.73+0.06 (+1.78%)

As of Oct 21, 2:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow RXRX in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on RXRX and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free RXRX chart →

RXRX at a glance

Key statistics

$1.96B

Market capitalization

Previous close
$3.66
Open
$3.67
Day range
$3.57 – $3.76
Volume
12.37M
Average volume (30 sessions)
28.23M
Shares outstanding
536.27M
Earnings per share
$(0.97)
Price / book
2.1
Price / sales
35.8
Beta (1 year, vs SPY)
2.95

Where the price sits in its year

52-week range

22% of the range

Below the 52-week high
-48.1%
Above the 52-week low
+34.5%

Completed sessions through Oct 20, 2026

Technical snapshot

Above its 50-day and 200-day averages

20-day average
$3.99-8.3%
50-day average
$3.64+0.5%
200-day average
$3.56+2.9%
RSI (14)47.1

Between the conventional 30 and 70 bands.

-4.6%

1 week

-7.8%

1 month

+22.8%

3 months

-10.5%

Year to date

-37.5%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with RXRX

From the public news wire

RXRX headlines

Market news →

SEC Form 4, most recent first

Insider filings

How to read these →
  • Borgeson Blake

    −50.0K

    Director · Open-market sale

    $242.00K · Oct 6, 2026

  • HERSHBERG ROBERT

    +25.0K

    Director · Option exercise

    $55.50K · Oct 6, 2026

  • HERSHBERG ROBERT

    −25.0K

    Director · Open-market sale

    $125.00K · Oct 6, 2026

  • HERSHBERG ROBERT

    −25.0K

    Director · Option exercise

    $55.50K · Oct 6, 2026

  • Dar Zavain

    +4.6K

    Director · Grant or award

    · Oct 1, 2026

  • Li Dean Y

    +3.4K

    Director · Grant or award

    · Oct 1, 2026

  • Taylor Ben R

    −5.4K

    Chief Financial Officer · Shares withheld for tax

    $18.40K · Sep 15, 2026

  • Khan Najat

    −22.4K

    CEO and President, Director · Open-market sale

    $78.82K · Sep 8, 2026

About Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Exchange
Nasdaq
Security
Common stock
Industry
Biological Products, (no Diagnostic Substances)
Headquarters
Salt Lake City, UT
Employees
600
Listed since
Apr 16, 2021
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.